ArticleDatabase : the journal of biological databases and curation2019
Automatic identification of relevant chemical compounds from patents.
Article in Database : the journal of biological databases and curation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- A Comparative Review of Artificial Intelligence Applications in Small Molecule Versus Peptide Drug Discovery.International journal of molecular sciences · 2026Review
- Summarizing relationships between chemicals, genes, proteins, and diseases in PubChem using analysis of their co-occurrences in patents.Journal of cheminformatics · 2025Article
- PatCID: an open-access dataset of chemical structures in patent documents.Nature communications · 2024Article
- OSPAR: A Corpus for Extraction of Organic Synthesis Procedures with Argument Roles.Journal of chemical information and modeling · 2023Article
- PubChem 2023 update.Nucleic acids research · 2023Article
- Deep learning-based automatic action extraction from structured chemical synthesis procedures.PeerJ. Computer science · 2023Article
- Multi-modal chemical information reconstruction from images and texts for exploring the near-drug space.Briefings in bioinformatics · 2022Article
- Old drugs, new tricks: leveraging known compounds to disrupt coronavirus-induced cytokine storm.NPJ systems biology and applications · 2022Article
- ChemTables: a dataset for semantic classification on tables in chemical patents.Journal of cheminformatics · 2021Article
- Congenericity of Claimed Compounds in Patent Applications.Molecules (Basel, Switzerland) · 2021Article
- Statistics of the Popularity of Chemical Compounds in Relation to the Non-Target Analysis.Molecules (Basel, Switzerland) · 2021Article
- NLM-Chem, a new resource for chemical entity recognition in PubMed full text literature.Scientific data · 2021Article
- From Tokenization to Self-Supervision: Building a High-Performance Information Extraction System for Chemical Reactions in Patents.Frontiers in research metrics and analytics · 2021Article
- ChEMU 2020: Natural Language Processing Methods Are Effective for Information Extraction From Chemical Patents.Frontiers in research metrics and analytics · 2021Article
- Automatic identification of relevant chemical compounds from patents.Database : the journal of biological databases and curation · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In commercial research and development projects, public disclosure of new chemical compounds often takes place in patents. Only a small proportion of these compounds are published in journals, usually a few years after the patent. Patent authorities make available the patents but do not provide systematic continuous chemical annotations. Content databases such as Elsevier's Reaxys provide such services mostly based on manual excerptions, which are time-consuming and costly. Automatic text-mining approaches help overcome some of the limitations of the manual process. Different text-mining approaches exist to extract chemical entities from patents. The majority of them have been developed using sub-sections of patent documents and focus on mentions of compounds. Less attention has been given to relevancy of a compound in a patent. Relevancy of a compound to a patent is based on the patent's context. A relevant compound plays a major role within a patent. Identification of relevant compounds reduces the size of the extracted data and improves the usefulness of patent resources (e.g. supports identifying the main compounds). Annotators of databases like Reaxys only annotate relevant compounds. In this study, we design an automated system that extracts chemical entities from patents and classifies their relevance. The gold-standard set contained 18 789 chemical entity annotations. Of these, 10% were relevant compounds, 88% were irrelevant and 2% were equivocal. Our compound recognition system was based on proprietary tools. The performance (F-score) of the system on compound recognition was 84% on the development set and 86% on the test set. The relevancy classification system had an F-score of 86% on the development set and 82% on the test set. Our system can extract chemical compounds from patents and classify their relevance with high performance. This enables the extension of the Reaxys database by means of automation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.